GFCR Decentralized (DCTI) Grant Program

Gateway for Cancer Research
Application Due Date
Brief Description

In May 2020, a new grant program funding research leveraging site-less, technology-informed trials was launched, with the objective of bringing clinical trials directly to patients’ doorsteps. 

Successful proposals will: 

  • Advance a treatment-based clinical trial in oncology
  • Emphasize the delivery of the investigational treatment in a decentralized setting, ideally home-based
  • Define compelling primary and secondary endpoints
  • Creatively leverage one or more innovative technologies (telemedicine, wearables, remote monitoring, medical record review, e-consent, etc.)
  • Have been reviewed with your CTO Administrative Director for regulatory, data management, and safety considerations related to implementation 
  • Integrate mobile clinician management as needed
  • Incorporate rigorous and methodical collection, management, and analysis of trial-related data
  • Utilize clinical resources in proximity and convenient to patients for any trial-related procedures that cannot practicably be carried out in a decentralized setting (e.g. imaging, interventional radiology, complex infusion, etc.)
  • Leverage strategic inter- and/or intra-institutional collaboration, including commercial (e.g. biopharmaceutical, CRO, home health companies, etc.)